Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pancreatitis
ADR ID BADD_A03269
ADR Hierarchy
07      Gastrointestinal disorders
07.18      Exocrine pancreas conditions
07.18.01      Acute and chronic pancreatitis
07.18.01.001      Pancreatitis
Description A disorder characterized by inflammation of the pancreas with no documented pancreas infection. [CTCAE] INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. [MeSH]
MedDRA Code 10033645
MeSH ID D010195
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Pancreatitis | Pancreatitis NOS | Pancreatitis steroid-induced | Pancreatitis aggravated | Mass forming pancreatitis | Toxic pancreatitis | Pancreatic inflammation | Pancreatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01624Orlistat0.019794%
BADD_D01629Osimertinib0.000750%
BADD_D01633Oxaliplatin--
BADD_D01635Oxaprozin--
BADD_D01637Oxcarbazepine0.000255%
BADD_D01653Paclitaxel--
BADD_D01656Paliperidone--
BADD_D01662Pamidronic acid--
BADD_D01668Pantoprazole0.000098%
BADD_D01674Parecoxib--
BADD_D01676Paricalcitol--
BADD_D01679Paroxetine--
BADD_D01684Pasireotide0.000373%
BADD_D01687Pazopanib0.001175%
BADD_D01692Pegaspargase--
BADD_D01701Pemetrexed--
BADD_D01702Pemetrexed disodium--
BADD_D01709Penicillamine--
BADD_D01717Pentamidine--
BADD_D01718Pentamidine isethionate--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01739Perindopril--
BADD_D01741Perindoprilat--
BADD_D01760Phenylbutyric acid--
BADD_D01767Phosphonatoformate--
BADD_D01771Pilocarpine hydrochloride--
BADD_D01777Pioglitazone--
BADD_D01783Pirfenidone--
BADD_D01784Piroxicam--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 19 Pages
ADReCS-Target
ADR Term Drug Name Target